共 198 条
[1]
Creutzig U(2012)Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel Blood 120 3187-3205
[2]
van den Heuvel-Eibrink MM(2013)Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia Blood 122 170-178
[3]
Gibson B(2017)Current management of childhood acute myeloid leukemia Paediatr Drugs 19 1-10
[4]
Dworzak MN(2017)Improved outcome of childhood acute myeloid leukemia in an Eastern European country: lithuanian experience Eur J Pediatr 176 1329-1337
[5]
Adachi S(2014)Cladribine in the treatment of acute myeloid leukemia Leuk Res 38 425-427
[6]
de Bont E(1996)Clinical and laboratory studies of 2-chlorodeoxyadenosine +/− cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults Leukemia 10 1563-1569
[7]
Pession A(2003)Purine nucleoside analogues in the treatment of myeloid leukemias Leuk Lymphoma 44 391-409
[8]
Masetti R(1996)Influence of fludarabine on pharmacokinetics and pharmacodynamics of cytarabine: implications for a continuous infusion schedule Clin Cancer Res 2 653-658
[9]
Rizzari C(1994)Use of G-CSF before, during and after fludarabine plus Cytarabine induction therapy of newly diagnosed AML or MDS: comparison with fludarabine plus Cytarabine without G-CSF J Clin Oncol 14 671-678
[10]
Putti MC(1996)Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions Blood 87 256-264